<scp>Anti‐CLL1</scp> ‐based <scp>CAR T</scp> ‐cells with <scp>4‐1‐BB</scp> or <scp>CD28</scp> / <scp>CD27</scp> stimulatory domains in treating childhood refractory/relapsed acute myeloid leukemia
Cancer medicine